NovaBay Pharmaceuticals Expands Sales Organization to Re-energize Growth

EMERYVILLE, Calif.--(BUSINESS WIRE)--$NBY #Avenova--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, announces it has completed the most recent planned expansion of its salesforce by hiring of 7 sales representatives. The Company now has a commercial salesforce of 45 representatives as the Company pursues profitable growth. “We are very encouraged by the high quality of our new hires, all of who

Full Story →